Concepedia

KR Flaherty

KF

Statistics

Publications

2

Citations

63

H-Index

2

Active since

2004

Affiliations

University of Washington(Current)

KR Flaherty is an author at University of Washington specializing in pulmonary fibrosis, pulmonary disease, and medicine.

Top concepts

Publications per year

2004–2015

2

Publications

2

Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis: Results of two 52-week, Phase III, randomized, placebo-controlled trials (INPULSIS™)

Ulrich Costabel, Luca Richeldi, RM du Bois et al. · Pneumologie · 2015 · 32 citations

, , +20

Safety and Tolerability of Human Monoclonal Antibody FG-3019, Anti-Connective Tissue Growth Factor, in Patients with Idiopathic Pulmonary Fibrosis

Yolanda Mageto, KR Flaherty, K. Brown et al. · CHEST Journal · 2004 · 31 citations · Full text

, , +9

Rows per page

1–2 of 2